Chemoinformaics analysis of SCILLARENIN-BETA-D-GLUCOSIDE
| Molecular Weight | 530.658 | nRot | 4 |
| Heavy Atom Molecular Weight | 488.322 | nRig | 33 |
| Exact Molecular Weight | 530.288 | nRing | 6 |
| Solubility: LogS | -3.601 | nHRing | 2 |
| Solubility: LogP | 2.568 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 6 |
| nHA | 8 | APOL | 84.5213 |
| nHD | 4 | BPOL | 48.2107 |
| QED | 0.438 |
| Synth | 4.936 |
| Natural Product Likeliness | 2.574 |
| NR-PPAR-gamma | 0.117 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.018 |
| Pgp-sub | 0.024 |
| HIA | 0.884 |
| CACO-2 | -4.965 |
| MDCK | 0.0000569 |
| BBB | 0.14 |
| PPB | 0.95096 |
| VDSS | 1.891 |
| FU | 0.037135 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.717 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.656 |
| CYP2c9-inh | 0.055 |
| CYP2c9-sub | 0.344 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.722 |
| CYP3a4-inh | 0.085 |
| CYP3a4-sub | 0.185 |
| CL | 1.905 |
| T12 | 0.07 |
| hERG | 0.028 |
| Ames | 0.051 |
| ROA | 0.959 |
| SkinSen | 0.012 |
| Carcinogencity | 0.21 |
| EI | 0.004 |
| Respiratory | 0.897 |
| NR-Aromatase | 0.729 |
| Antiviral | Yes |
| Prediction | 0.851239 |